Type 2 Diabetes: Dapansutrile Study

We are testing a new oral medication for people with type 2 diabetes to see if it helps lower blood sugar levels better than a placebo. The study also looks at its safety and effects on insulin function.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Dapansutrile

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre hospitalier universitaire de Liege
Département de Médecine, Service de Diabétologie, Nutrition et Maladies Métaboliques
Tilff, Belgium
Assistance Publique Hopitaux De Paris
Hôpital Lariboisière APHP-Service de Diabétologie, Endocrinologie
Angers, France
Assistance Publique Hopitaux De Paris
Hôpital Bichat Claude-Bernard - Service de Diabétologie, Endocrinologie
Saint-Ouen, France

Sponsor: Kantonsspital Baden AG
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.